Advisers See No Data Favoring Trump-Touted Plasma Therapy (1)

A panel of experts convened by the National Institutes of Health undercut an emergency authorization issued just days ago by U.S. regulators, saying there’s not enough evidence to recommend use of convalescent plasma for hospitalized coronavirus patients.

In an escalation of a dispute between federal agencies, the NIH advisers said an analysis of a study showed “no difference in 7-day survival overall” among those who received plasma containing high amounts of antibodies.

Stephen Hahn

The statement contradicts inflated claims made at an unusual Sunday night press conference at the White House a week ago, where Food and Drug Administration Commissioner Stephen ...